The price of Pacific Biosciences of California Inc (NASDAQ:PACB) shares last traded on Wall Street fell -6.10% to $1.54.
PACB stock price is now -13.85% away from the 50-day moving average and -13.55% away from the 200-day moving average. The market capitalization of the company currently stands at $421.75M.
In other news, Farmer Michele, insider sold 24,349 shares of the company’s stock on Feb 18 ’25. The stock was sold for $45,727 at an average price of $1.88. Upon completion of the transaction, the insider now directly owns 187,592 shares in the company, valued at $0.29 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Feb 18 ’25, Van Oene Mark sold 100,773 shares of the business’s stock. A total of $189,252 was realized by selling the stock at an average price of $1.88. This leaves the insider owning 1,496,681 shares of the company worth $2.3 million. A total of 18.71% of the company’s stock is owned by insiders.
During the past 12 months, Pacific Biosciences of California Inc has had a low of $1.16 and a high of $6.09. As of last week, the company has a debt-to-equity ratio of 1.32, a current ratio of 12.63, and a quick ratio of 11.13.
The net profit margin was -200.40% and return on equity was -51.05% for PACB. The company reported revenue of $39.97 million for the quarter, compared to $55.69 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue fell -28.23 percent.
